Your browser doesn't support javascript.
loading
Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine.
Lai, Haoqiang; Xu, Ligeng; Liu, Chang; Shi, Sujiang; Jiang, Yalin; Yu, Yangyang; Deng, Bo; Chen, Tianfeng.
Affiliation
  • Lai H; Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
  • Xu L; Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China. lgxu19@jnu.edu.cn.
  • Liu C; Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
  • Shi S; Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
  • Jiang Y; Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
  • Yu Y; Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
  • Deng B; Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
  • Chen T; Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China. tchentf@jnu.edu.cn.
Signal Transduct Target Ther ; 8(1): 88, 2023 02 27.
Article in En | MEDLINE | ID: mdl-36849546
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Selenium / COVID-19 Language: En Journal: Signal Transduct Target Ther Year: 2023 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Selenium / COVID-19 Language: En Journal: Signal Transduct Target Ther Year: 2023 Type: Article Affiliation country: China